Hemophilia More Prevalent Than Previously Estimated
|
By HospiMedica International staff writers Posted on 01 Oct 2019 |
|
A new study reveals that over 1,125,000 men around the world have inherited hemophilia, three times more than previously estimated.
Researchers at McMaster University (Hamilton, ON, Canada), the World Federation of Hemophilia (WFH; Montréal, Canada), and other institutions conducted a random-effects meta-analysis of registry data from Australia, Canada, France, Italy, New Zealand, and the United Kingdom in order to estimate the prevalence and prevalence at birth of male patients with hemophilia A or B in proportion to total male population, life expectancy disadvantage as related to prevalence at birth, and the expected number of patients worldwide.
The results revealed a prevalence of hemophilia A of 17.1 cases per 100,000 males for all severities of hemophilia, six cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, five cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage (in high-income countries) is thus 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The study was published on September 10, 2019, in Annals of Internal Medicine.
“The expected number of patients with hemophilia worldwide is 1,125,000, of whom 418,000 should have severe hemophilia,” said lead author Professor Alfonso Iorio, MD, PhD, director of the Hamilton-Niagara hemophilia program at McMaster University. “Knowing how many patients are out there will enable health care systems to estimate the resources needed to treat the disease, and enable drug manufacturers to increase the investment in research to match the demand of a patient population three times larger than we previously thought.”
Hemophilia, which is found almost only in men, is caused by a genetic defect. The most common type is hemophilia A, due to a lack of clotting factor VIII. Hemophilia B, which is less common, is caused by a lack in factor IX. Hemophilia is currently treated with infusions of the missing factors to prevent or stop debilitating bleeds, but treatment is expensive and scarce in many countries. Lack of treatment leads to chronic, disabling joint disease, while bleeding into organs and brain hemorrhages can lead to disability and death.
Related Links:
McMaster University
World Federation of Hemophilia
Researchers at McMaster University (Hamilton, ON, Canada), the World Federation of Hemophilia (WFH; Montréal, Canada), and other institutions conducted a random-effects meta-analysis of registry data from Australia, Canada, France, Italy, New Zealand, and the United Kingdom in order to estimate the prevalence and prevalence at birth of male patients with hemophilia A or B in proportion to total male population, life expectancy disadvantage as related to prevalence at birth, and the expected number of patients worldwide.
The results revealed a prevalence of hemophilia A of 17.1 cases per 100,000 males for all severities of hemophilia, six cases for severe hemophilia A, 3.8 cases for all severities of hemophilia B, and 1.1 cases for severe hemophilia B. Prevalence at birth is 24.6 cases for all severities of hemophilia A, 9.5 cases for severe hemophilia A, five cases for all severities of hemophilia B, and 1.5 cases for severe hemophilia B. The life expectancy disadvantage (in high-income countries) is thus 30% for hemophilia A, 37% for severe hemophilia A, 24% for hemophilia B, and 27% for severe hemophilia B. The study was published on September 10, 2019, in Annals of Internal Medicine.
“The expected number of patients with hemophilia worldwide is 1,125,000, of whom 418,000 should have severe hemophilia,” said lead author Professor Alfonso Iorio, MD, PhD, director of the Hamilton-Niagara hemophilia program at McMaster University. “Knowing how many patients are out there will enable health care systems to estimate the resources needed to treat the disease, and enable drug manufacturers to increase the investment in research to match the demand of a patient population three times larger than we previously thought.”
Hemophilia, which is found almost only in men, is caused by a genetic defect. The most common type is hemophilia A, due to a lack of clotting factor VIII. Hemophilia B, which is less common, is caused by a lack in factor IX. Hemophilia is currently treated with infusions of the missing factors to prevent or stop debilitating bleeds, but treatment is expensive and scarce in many countries. Lack of treatment leads to chronic, disabling joint disease, while bleeding into organs and brain hemorrhages can lead to disability and death.
Related Links:
McMaster University
World Federation of Hemophilia
Gold Member
12-Channel ECG
CM1200B
Medical Examination & Procedure Light
Vega 80
Vessel Sealing Instrument
ERGOseal
Latest Critical Care News
- Invisible Skin Sensors Could Transform Everyday Biosignal Monitoring
- Patient-Specific Artery-on-a-Chip Refines Stroke Risk Stratification
- Existing Cardiovascular Risk Calculators Predict Several Common Cancers
- New Neurovascular Guidewire Enhances Access and Control in Stroke Thrombectomy
- AI Tool Automates EEG Analysis and Flags Clinically Relevant Abnormalities
- New Risk Models Improve Sudden Cardiac Arrest Prediction
- Low-Cost Antiseptic Regimen Reduces Bacteria Linked to Newborn Infections
- Collaborative ICU Admission Process Cuts Time to Critical Care Involvement by Half
- AI System Predicts Heart Failure Risk Years in Advance from Holter ECG
- Wearable Microneedle Patch Monitors Antibiotic Levels in Real Time
- AI Analysis of EMS Calls Aids Pediatric Trauma Decision-Making
- Noninvasive Silk Sensor Could Transform Care for Premature Infants
- AI Tool Supports Noninvasive Continuous Dyspnea Monitoring in Ventilated Patients
- AI Identifies Hidden Stroke Risk Through At-Home Behavior Patterns
- Home Exercise Program Advances Recovery After Aortic Dissection
- Multi-Night Home Monitoring Reduces Sleep Apnea Misdiagnosis
Channels
Artificial Intelligence
view channel
New AI Tool Identifies Support Needs in Spinal Cord Stimulation
Chronic pain patients implanted with spinal cord stimulation systems often need timely therapy adjustments and education between clinic visits. Detecting subtle changes in behavior or device use that precede... Read more
AI Tool Predicts Chronic Kidney Disease Risk in Diabetes
Chronic kidney disease is a common and serious complication of type 2 diabetes and often progresses without obvious early symptoms, increasing morbidity and straining health systems. Many risk models were... Read more
Surgical Techniques
view channel
Reusable Pulse Oximetry Sensor Improves Accuracy Across Skin Tones
Pulse oximetry is ubiquitous in critical and perioperative care, guiding interventions by indicating a patient’s oxygenation status. Yet signal quality can be affected by physiological, clinical, and technical... Read more
Implantable Neural Interface Undergoes First Real-World Surgical Validation
ABILITY Neurotech has initiated first-in-human evaluation of its fully implantable brain-computer interface (BCI) at the Department of Neurosurgery, Technical University of Munich (TUM) University Hospital... Read more
Patient Care
view channel
AI Avatar Doctor Improves Patient Understanding Before Radiotherapy
Radiation oncology consultations require patients to grasp complex concepts quickly, yet anxiety and information overload often undermine understanding and informed consent. Poor comprehension can also... Read more
Wearable Sleep Data Predict Adherence to Pulmonary Rehabilitation
Chronic obstructive pulmonary disease (COPD) is a long-term lung disorder that makes breathing difficult and often disturbs sleep, reducing energy for daily activities. Limited engagement in pulmonary... Read more
Health IT
view channel
Smartwatch Monitoring Identifies Abnormal Vital Signs Before Routine Checks
Post-surgical inpatients often undergo frequent vital signs checks that interrupt rest and require substantial nursing time. Intermittent manual observations can also delay recognition of early physiological... Read more
Weekly Remote Symptom Monitoring Improves Symptom Control in Advanced Cancer
Patients receiving treatment for advanced cancer often struggle with uncontrolled symptoms and fragmented communication with clinicians. These gaps can impair daily function, increase emergency department... Read more
Point of Care
view channel
New Brain Ultrasound Platform Enables Bedside Postoperative Imaging
Transporting postoperative patients for CT or MRI can create operational burdens, delays, and disruptions in care. Bedside visualization may help reduce transport demands, lower radiation exposure, and... Read more
Handheld Ultrasound Expands Point-of-Care Imaging Access in Brazil
Rapid access to diagnostic imaging is essential across hospitals, emergency departments, clinics, and municipal health systems, but large markets still face uneven availability, particularly in rural regions.... Read more
Business
view channel
AI Care Platform Adds Quantitative MRI Analysis for Multiple Sclerosis
Neurodegenerative diseases such as multiple sclerosis require timely identification and coordinated, long-term management. As health systems seek consistent decision-making at scale, quantitative neuroimaging... Read more
